{"title":"锂与慢性肾病:停还是不停?","authors":"Bharat Velani, R. Tomar","doi":"10.1002/pnp.786","DOIUrl":null,"url":null,"abstract":"Lithium is the first‐line treatment as a mood stabiliser in bipolar affective disorder, but it is associated with an increased risk of developing chronic kidney disease (CKD). Consideration of ongoing lithium therapy in patients with CKD is a relatively common clinical scenario, but there is a lack of clear clinical guidelines and management practices vary. We discuss two cases of patients on lithium therapy who developed CKD, in order to provide a meaningful context to further explore the clinical framework for decision making and management.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":" ","pages":""},"PeriodicalIF":1.3000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lithium and chronic kidney disease: to stop or not to stop?\",\"authors\":\"Bharat Velani, R. Tomar\",\"doi\":\"10.1002/pnp.786\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Lithium is the first‐line treatment as a mood stabiliser in bipolar affective disorder, but it is associated with an increased risk of developing chronic kidney disease (CKD). Consideration of ongoing lithium therapy in patients with CKD is a relatively common clinical scenario, but there is a lack of clear clinical guidelines and management practices vary. We discuss two cases of patients on lithium therapy who developed CKD, in order to provide a meaningful context to further explore the clinical framework for decision making and management.\",\"PeriodicalId\":43913,\"journal\":{\"name\":\"Progress in Neurology and Psychiatry\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2023-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Progress in Neurology and Psychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/pnp.786\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Neurology and Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/pnp.786","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
Lithium and chronic kidney disease: to stop or not to stop?
Lithium is the first‐line treatment as a mood stabiliser in bipolar affective disorder, but it is associated with an increased risk of developing chronic kidney disease (CKD). Consideration of ongoing lithium therapy in patients with CKD is a relatively common clinical scenario, but there is a lack of clear clinical guidelines and management practices vary. We discuss two cases of patients on lithium therapy who developed CKD, in order to provide a meaningful context to further explore the clinical framework for decision making and management.
期刊介绍:
Progress in Neurology and Psychiatry is published nine times a year, and is a journal for specialists in secondary care, GPs with an interest in neurology and psychiatry, community psychiatric nurses and other specialist healthcare professionals. Articles cover management, news updates and opinion in all areas of neurology and psychiatry.